Outcome of COVID-19 in Kidney Transplant Recipients Through the SARS-CoV-2 Variants Eras: Role of Anti-SARS-CoV-2 Monoclonal Antibodies.
COVID-19
SARS-CoV-2
kidney transplantation
monoclonal antibodies
outcome
vaccination
Journal
Transplant international : official journal of the European Society for Organ Transplantation
ISSN: 1432-2277
Titre abrégé: Transpl Int
Pays: Switzerland
ID NLM: 8908516
Informations de publication
Date de publication:
2022
2022
Historique:
received:
23
06
2022
accepted:
20
09
2022
entrez:
21
10
2022
pubmed:
22
10
2022
medline:
25
10
2022
Statut:
epublish
Résumé
Kidney transplant recipients (KTR) are at increased risk for COVID-19-associated complications. We aimed to describe the evolving epidemiology and outcome of PCR-documented SARS-CoV-2 infection in KTR followed at our institution from March 2020 to May 2022. The primary endpoint was hospitalization for COVID-19-related symptoms or death within 28 days from diagnosis. Overall, 243 cases were included of which 68 (28%) developed the primary outcome. A significant decrease in the incidence of the primary outcome was observed (
Identifiants
pubmed: 36267693
doi: 10.3389/ti.2022.10721
pii: 10721
pmc: PMC9576844
doi:
Substances chimiques
Antibodies, Monoclonal
0
Antibodies, Viral
0
casirivimab
J0FI6WE1QN
imdevimab
2Z3DQD2JHM
sotrovimab
1MTK0BPN8V
Spike Glycoprotein, Coronavirus
0
spike protein, SARS-CoV-2
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
10721Informations de copyright
Copyright © 2022 Papadimitriou-Olivgeris, Cipriano, Guggisberg, Kroemer, Tschopp, Manuel and Golshayan.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Kidney Int Rep. 2022 Jun;7(6):1241-1247
pubmed: 35372734
Nature. 2022 Feb;602(7898):664-670
pubmed: 35016195
Transplantation. 2022 May 1;106(5):e275-e276
pubmed: 35283456
Am J Transplant. 2021 Mar;21(3):925-937
pubmed: 33319449
N Engl J Med. 2021 Nov 18;385(21):1941-1950
pubmed: 34706189
J Virol. 2021 Jan 13;95(3):
pubmed: 33144321
Am J Transplant. 2020 Oct;20(10):2876-2882
pubmed: 32412159
Transpl Infect Dis. 2022 Feb;24(1):e13759
pubmed: 34787345
Transplantation. 2021 Jan 1;105(1):37-55
pubmed: 33148977
Lancet. 2022 Apr 2;399(10332):1303-1312
pubmed: 35305296
Open Forum Infect Dis. 2021 Jun 07;8(6):ofab255
pubmed: 34631921
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Transplantation. 2021 Jul 1;105(7):e68-e69
pubmed: 33724242
J Clin Invest. 2021 Jul 15;131(14):
pubmed: 34101623
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Lancet. 2022 Feb 12;399(10325):665-676
pubmed: 35151397
Transpl Infect Dis. 2022 Apr;24(2):e13809
pubmed: 35148028
Clin Transplant. 2021 Apr;35(4):e14245
pubmed: 33595145
Microbiol Spectr. 2022 Aug 31;10(4):e0092622
pubmed: 35700134
J Infect Dis. 2021 Oct 28;224(8):1278-1286
pubmed: 34279629
Curr Transplant Rep. 2022;9(1):26-34
pubmed: 35070639
N Engl J Med. 2021 Aug 12;385(7):661-662
pubmed: 34161700
JAMA Oncol. 2022 May 1;8(5):e220446
pubmed: 35271706
Nature. 2022 Feb;602(7898):671-675
pubmed: 35016199
Lancet. 2022 Apr 23;399(10335):1618-1624
pubmed: 35397851
Infect Dis Ther. 2021 Dec;10(4):2479-2488
pubmed: 34435337
Transpl Infect Dis. 2022 Apr;24(2):e13788
pubmed: 34989104
Viruses. 2021 Apr 25;13(5):
pubmed: 33923063
Am J Transplant. 2021 Aug;21(8):2719-2726
pubmed: 33866672
Transpl Infect Dis. 2021 Oct;23(5):e13705
pubmed: 34324256
JAMA. 2021 May 4;325(17):1784-1786
pubmed: 33720292
Am J Transplant. 2022 Jan;22(1):279-288
pubmed: 34514710